MKI67 and neoplasm: Routine H&E staining revealed a marked increase in the extent of necrosis in tumors from mice treated with either single agent sorafenib or the drug combination Ki-67 staining and TUNEL assays limited to areas of tumor that were not overtly necrotic revealed no differences among the treatment groups (data not shown).